Abstract
Goeckerman's method of therapy for psoriasis includes combined exposure to therapeutic tar and UV-B radiation. In this pilot study (13 patients) the level of genotoxic risk of therapy was evaluated by using the chromosomal aberration of the peripheral lymphocytes.
This study suggeted the presence of an increased genotoxic risk in the therapy.